Sonendo Past Earnings Performance

Past criteria checks 0/6

Sonendo's earnings have been declining at an average annual rate of -8.5%, while the Medical Equipment industry saw earnings growing at 13.5% annually. Revenues have been growing at an average rate of 19.5% per year.

Key information

-8.5%

Earnings growth rate

89.7%

EPS growth rate

Medical Equipment Industry Growth8.9%
Revenue growth rate19.5%
Return on equity-214.4%
Net Margin-138.9%
Next Earnings Update08 May 2024

Recent past performance updates

Recent updates

Analysts Have Just Cut Their Sonendo, Inc. (NYSE:SONX) Revenue Estimates By 18%

Nov 10
Analysts Have Just Cut Their Sonendo, Inc. (NYSE:SONX) Revenue Estimates By 18%

A Piece Of The Puzzle Missing From Sonendo, Inc.'s (NYSE:SONX) Share Price

Apr 19
A Piece Of The Puzzle Missing From Sonendo, Inc.'s (NYSE:SONX) Share Price

Sonendo unit PIPStek files patent infringement lawsuit against Biolase

Jan 04

GAAP EPS of -$0.47 misses by $0.08, revenue of $9.8M beats by $0.49M

Nov 09

Sonendo announces $63 million private placement

Sep 23

Sonendo: Painful Debut For This Dental Play

Nov 07

Revenue & Expenses Breakdown
Beta

How Sonendo makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:SONX Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 2344-615412
30 Sep 2344-615713
30 Jun 2344-595715
31 Mar 2343-575515
31 Dec 2242-575217
30 Sep 2239-604917
30 Jun 2237-574518
31 Mar 2235-533918
31 Dec 2133-483419
30 Sep 2132-473020
30 Jun 2130-452721
31 Mar 2127-462621
31 Dec 2023-472720
31 Dec 1935-493619

Quality Earnings: SONX is currently unprofitable.

Growing Profit Margin: SONX is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: SONX is unprofitable, and losses have increased over the past 5 years at a rate of 8.5% per year.

Accelerating Growth: Unable to compare SONX's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: SONX is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (3.3%).


Return on Equity

High ROE: SONX has a negative Return on Equity (-214.36%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.